BFM
KZR

Boothbay Fund Management’s Kezar Life Sciences KZR Stock Holding History

Boothbay Fund Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Hold
16,210
– – ﹤0.01% 1857
2025
Q4 		$102K Sell
16,210
-4,690
-22% -$27.4K ﹤0.01% 1737
2025
Q3 		$81.5K Hold
20,900
– – ﹤0.01% 1749
2025
Q2 		$95.7K Hold
20,900
– – ﹤0.01% 1312
2025
Q1 		$102K Hold
20,900
– – ﹤0.01% 1227
2024
Q4 		$140K Buy
20,900
+1
+0% +$7 ﹤0.01% 1241
2024
Q3 		$162K Buy
20,899
+5,850
+39% +$35.3K ﹤0.01% 1413
2024
Q2 		$90.3K Hold
15,049
– – ﹤0.01% 1363
2024
Q1 		$136K Buy
15,049
+1,561
+12% +$14.2K ﹤0.01% 1387
2023
Q4 		$128K Hold
13,488
– – ﹤0.01% 1401
2023
Q3 		$161K Buy
13,488
+1,179
+10% +$20.9K ﹤0.01% 1475
2023
Q2 		$302K Hold
12,309
– – 0.01% 1294
2023
Q1 		$385K Buy
12,309
+4,332
+54% +$251K 0.01% 1378
2022
Q4 		$562K Sell
7,977
-387
-5% -$28.7K 0.01% 1129
2022
Q3 		$720K Sell
8,364
-7,810
-48% -$759K 0.02% 1048
2022
Q2 		$1.34M Buy
16,174
+4,869
+43% +$429K 0.04% 702
2022
Q1 		$1.88M Hold
11,305
– – 0.04% 603
2021
Q4 		$1.89M Buy
+11,305
New +$1.28M 0.04% 502

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Boothbay Fund Management's KZR Position: Q1 2026 in Review

Boothbay Fund Management held its Kezar Life Sciences (KZR) position steady in Q1 2026 at 16,210 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Boothbay Fund Management first reported a position in KZR in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.89M in Q4 2021. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Boothbay Fund Management held 16,210 shares of Kezar Life Sciences worth $120K as of Q1 2026.
  • Boothbay Fund Management left its Kezar Life Sciences share count unchanged in Q1 2026.
  • Kezar Life Sciences made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1857 holding.
  • Boothbay Fund Management first reported a position in Kezar Life Sciences in Q4 2021 and has held it in 18 quarters since.
  • Boothbay Fund Management's Kezar Life Sciences position peaked at $1.89M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.